3M Combat Arms Earplug Lawsuit: Where the $6B Settlement Stands
The largest mass tort in U.S. history began with a whistleblower's fraud suit and a failed subsidiary bankruptcy. Over half the $6 billion has now been paid.
Where major multidistrict litigations actually stand: what a federal MDL is, how it differs from a class action, current settlement status, and how to tell whether a specific mass tort claim is still open.
The largest mass tort in U.S. history began with a whistleblower's fraud suit and a failed subsidiary bankruptcy. Over half the $6 billion has now been paid.
A federal judge ruled a chatbot's output isn't clearly protected speech, letting product liability and wrongful death claims proceed. One case already settled.
The first bellwether ended in a defense win on warnings and a hung jury on design. The second, testing fracture claims, started August 18, 2026.
A secret 2021 deal shielded Boeing from prosecution. A judge ruled crash victims should have been consulted first — then said he couldn't fix it.
Lawyers projected up to $25,000 per person for personal injury. Actual checks averaged about $12,400. Objectors who fought it lost over an unpaid bond.
Quartz countertop dust is sickening workers after just a few years, not decades. A $52 million verdict landed in 2024. Congress may now try to block it all.
Bard is settling roughly 38,000 cases. Covidien just lost an $88 million bellwether. Four different manufacturers means four different postures.
One manufacturer has resolved over 8,600 cases quietly. The other just lost its second bellwether trial and is only now heading toward settlement talks.
Federal bellwethers against Similac and Enfamil have been thrown out before reaching a jury. State courts have awarded $495 million and $70 million.
Nearly 4,000 cases allege gastroparesis or vision loss from GLP-1 drugs. No trial has happened — but a hearing this September could decide who ever gets one.
A $50 billion national settlement mostly pays governments, not victims. A Supreme Court ruling then blew up the one fund built for individuals.
A federal appeals court just reinstated over 500 Tylenol autism lawsuits, reversing the 2024 ruling that had shut the litigation down entirely.
GSK settled for $2.2 billion. Boehringer just got 80,000 Delaware cases dismissed. Which one matters depends on which Zantac you took, and when.
Water utilities already settled for over $13 billion. Firefighters and veterans with cancer are still waiting — their claims are a separate, unresolved fight.
A 2005 federal law shields gun makers and sellers from most lawsuits over criminal misuse — but its exceptions are real and narrower than assumed.
Liability is rarely the fight in a foodborne illness claim. Causation is — and a lab sample is what usually decides it.
A federal judge's pending ruling on general causation could decide over 5,000 cases at once — this litigation's whole future turns on a single Daubert decision.
Most vaccine injury claims cannot go to court at all. A federal no-fault program decides them first, on its own three-year deadline.
The deadline to file a new Camp Lejeune claim passed in August 2024. Here's what that actually means, and where the roughly 3,750 pending lawsuits stand now.
One of the fastest-growing pharmaceutical MDLs ever, with a settlement in principle reached in June 2026 — but not yet finalized.
Over 11,000 pending claims, a court-appointed Special Master negotiating talks, but still no global settlement in the federal MDL.
Mass tort isn't a formal legal category. What an MDL actually is, how it differs from a class action, and how to check a litigation's real status yourself.
Not every product injury needs a mass tort. Design defect, manufacturing defect and failure to warn are three distinct theories to know.
A Supreme Court ruling limited some claims in June 2026; a separate $7.25 billion Missouri settlement still awaits final approval.
Real jury verdicts, not just filed complaints: how litigation against Meta, TikTok, Snap and YouTube over youth mental health harm is playing out in 2026.
J&J's three bankruptcy attempts failed; a $5.5 billion settlement was announced in July 2026 — but it isn't final. Here's exactly what has and hasn't happened.